Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer

Journal of RNAi and Gene Silencing

Volumn 9, Issue 1, 2013, Pages 479-485

  Orio, Julie ^a,b   Bellard, Elisabeth ^a,b   Baaziz, Houda ^a,b   Pichon, Chantal ^c   Mouritzen, Peter ^d   Rols, Marie Pierre ^a,b   Teissié, Justin ^a,b   Golzio, Muriel ^a,b   Chabot, Sophie ^a,b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d Exiqon AS   (Denmark)

Author keywords

Cyanine 5 labeling; Electroporation; Electropulsation; Fluorescence microscopy; Locked nucleic acid; Rnai

Indexed keywords

CYANINE DYE 5; DNA; FLUORESCENT DYE; LOCKED NUCLEIC ACID; LOCKED NUCLEIC ACID DNA OLIGOMER; LYSOTRACKER GREEN DND 26; MITOTRACKER GREEN FM; OLIGOMER; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL NUCLEUS; CELL ORGANELLE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CYTOPLASM; ELECTRICAL PARAMETERS; ELECTROPORATION; ENDOCYTOSIS; ENDOSOME; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGING SOFTWARE; LASER FLUORESCENCE DEVICE; LYSOSOME; MITOCHONDRION;

EID: 84887582811     PISSN: 17470854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alam MR, Dixit V, Kang H et al. 2008. Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis. Nucleic Acids Res, 36, 2764-4776.
2. Belitsky JM, Leslie SJ, Arora PS et al. 2002. Cellular uptake of N-methylpyrrole/N-methylimidazole polyamide-dye conjugates. Bioorg Med Chem, 10, 3313-3318.
3. Braasch DA and Corey DR. 2001. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem Biol, 8, 1-1.
4. Braasch DA, Liu Y and Corey DR. 2002. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res, 30, 5160-0167.
5. Chabot S, Orio J, Castanier R et al. 2012. LNA-based oligonucleotide electrotransfer for miRNA inhibition. Mol Ther, 20, 1590-0598.
6. Chabot S, Pelofy S, Paganin-Gioanni A et al. 2011. Electrotransfer of RNAi-based oligonucleotides for oncology. Anticancer Res, 31, 4083-3089.
7. Corey DR. 2007. Chemical modification: the key to clinical application of RNA interference? J Clin Invest, 117, 3615-5622.
8. Corsten MF, Miranda R, Kasmieh R et al. 2007. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res, 67, 8994-4000.
9. Elbashir SM, Harborth J, Lendeckel W et al. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411, 494-498.
10. Elmen J, Thonberg H, Ljungberg K et al. 2005. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res, 33, 439-947.
11. Escoffre JM, Portet T, Wasungu L et al. 2009. What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues. Mol Biotechnol, 41, 286-695.
12. Fire A, Xu S, Montgomery MK et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-611.
13. Golzio M, Mazzolini L, Ledoux A et al. 2007. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery. Gene Ther, 14, 752-259.
14. Golzio M, Mazzolini L, Moller P, Rols MP and Teissie J. 2005. Inhibition of gene expression in mice muscle by in vivo electrically mediated siRNA delivery. Gene Ther, 12, 246-651.
15. Golzio M, Teissie J and Rols MP. 2002. Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci U S A, 99, 1292-2297.
16. He L, Thomson JM, Hemann MT et al. 2005. A microRNA polycistron as a potential human oncogene. Nature, 435, 828-833.
17. Heil F, Hemmi H, Hochrein H et al. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science, 303, 1526-6529.
18. Juliano R, Alam MR, Dixit V et al. 2008. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res, 36, 4158-8171.
19. Kaur H, Babu BR and Maiti S. 2007. Perspectives on chemistry and therapeutic applications of Locked Nucleic Acid (LNA). Chem Rev, 107, 4672-2697.
20. Lagos-Quintana M, Rauhut R, Lendeckel W et al. 2001. Identification of novel genes coding for small expressed RNAs. Science, 294, 853-358.
21. Lorenz S, Tomcin S and Mailander V. 2011. Staining of mitochondria with Cy5-labeled oligonucleotides for long-term microscopy studies. Microsc Microanal, 17, 440-045.
22. Marcusson EG, Bhat B, Manoharan M et al. 1998. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res, 26, 2016-6023.
23. Mir LM, Glass LF, Sersa G et al. 1998. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer, 77, 2336-6342.
24. Neumann E, Schaefer-Ridder M, Wang Y et al. 1982. Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J, 1, 841-145.
25. Osman A. 2012. MicroRNAs in health and disease--basic science and clinical applications. Clin Lab, 58, 393-302.
26. Paganin-Gioanni A, Bellard E, Couderc B et al. 2008. Tracking in vitro and in vivo siRNA electrotransfer in tumor cells. J RNAi Gene Silencing, 4, 281-188.
27. Paganin-Gioanni A, Bellard E, Escoffre JM et al. 2011. Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells. Proc Natl Acad Sci U S A, 108, 10443-30447.
28. Pelofy S, Teissie J, Golzio M et al. 2012. Chemically Modified Oligonucleotide-Increased Stability Negatively Correlates with Its Efficacy Despite Efficient Electrotransfer. J Membr Biol, 245, 565-571.
29. Rhee WJ and Bao G. 2010. Slow non-specific accumulation of 2'-deoxy and 2'-O-methyl oligonucleotide probes at mitochondria in live cells. Nucleic Acids Res, 38, e109.
30. Stein CA, Hansen JB, Lai J et al. 2010. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res, 38, e3.
31. Stenvang J, Silahtaroglu AN, Lindow M et al. 2008. The utility of LNA in microRNA-based cancer diagnostics and therapeutics. Semin Cancer Biol, 18, 89-902.
32. Teissie J, Golzio M and Rols MP. 2005. Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta, 1724, 270-080.
33. Teissie J and Rols MP. 1993. An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys J, 65, 409-913.
34. Testori A, Rossi CR and Tosti G. 2012. Utility of electrochemotherapy in melanoma treatment. Curr Opin Oncol, 24, 155-561.
35. Wheeler TM, Leger AJ, Pandey SK et al. 2012. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature, 488, 111-115.
36. Zhang C, Liu T, Su Y et al. 2010. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials, 31, 6612-2617.
37. Zhang Y, Qu Z, Kim S et al. 2011. Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection. Gene Ther, 18, 326-633.